Neoadjuvant treatment for locally advanced rectal carcinoma

Critical Reviews in Oncology/Hematology

Volumn 52, Issue 1, 2004, Pages 61-71

  Pasetto, Lara Maria ^a   Pucciarelli, Salvatore ^a   Agostini, Marco ^a   Rossi, Elena ^a   Monfardini, Silvio ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Chemoradiotherapy; Neoadjuvant; Rectal cancer; Review

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; RALTITREXED; TEGAFUR;

ABDOMINAL CRAMP; ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DIARRHEA; ERYTHEMA; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RADIATION DOSE; RADIATION INJURY; RECTUM CARCINOMA; RECTUM RESECTION; REVIEW; TREATMENT INDICATION; WOUND HEALING IMPAIRMENT;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 4444283789     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2004.07.001     Document Type: Review

References (103)

1. S.H. Landis, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics Cancer J Clin 49 1999 8 31
2. American Joint Committee on Cancer (AJCC). In: Fleming DI, Coper SJ, Henson ED, Hutter VR, Kennedy JB, Murphy PG, O'Sullivan B, Sobin HL, Yarbro WJ, editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 83-90.
3. NIH Consensus Conference Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1990 1444 1450
4. R.J. Heald, R.K. Smedh, A. Kald, R. Sexton, and B.J. Moran Abdominoperineal excision of the rectum - an endangered operation Norman Nigro Lectureship Dis Colon Rectum 40 1997 747 751
5. J.K. McFarlane, R.D.H. Ryall, and R.J. Heald Mesorectal excision for rectal cancer Lancet 341 1993 457 460
6. M. Dahlberg, B. Glimelius, and L. Pahlman Changing strategy for rectal cancer is associated with improved outcome Br J Surg 86 3 1999 379 384
7. A. Wibe, P.R. Rendedal, E. Svensson Norwegian Rectal Cancer Group Br J Surg 89 3 2002 327 334
8. F. Kockerling, M.A. Reymond, A. Altendorf-Hofmann, O. Dworak, and W. Hohenberger Influence of surgery on metachronous distant metastases and survival in rectal cancer J Clin Oncol 16 1998 324 329
9. R.J. Aitken Mesorectal excision for rectal cancer Br J Surg 83 1996 214 216
10. P. Quirke, P. Dardy, M.F. Dixon, and N.S. Williams Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathologic study of lateral tumour spread and surgical excision Lancet 2 1986 996 999
11. I.J. Adam, M.O. Mohamdee, and I.G. Martin Role of circumferential margin involvement in the local recurrence of rectal cancer Lancet 344 1994 707 711
12. I.D. Nagtegaal, C.A. Marijnen, and E.K. Kranenbarg Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer J Pathol 197 2002 20 27
13. E. Kapiteijn, C. Marijnen, I. Nagtegaal Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 2001 638 646
14. D. Sebag-Montefiore, T. Maughan, and S. Falk A phase I dose escalation study of oxaliplatin when given in combination with 5-Fluorouracil (5FU), low dose folinic acid (LDFA) and synchronous preoperative radiotherapy (RT) in locally advanced rectal cancer Proc Am Soc Clin Oncol 20 2001 147 [abstract 585]
15. Swedish Rectal Cancer Trial Improved survival with preoperative radiotherapy in resectable rectal cancer N Engl J Med 336 1997 980 987
16. T. Holm, L.E. Rutqvist, H. Johannson, and B. Cedrmark Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors Br J Surg 83 1996 964 968
17. C. Camma, M. Giunta, and F. Fiorica Preoperative radiotherapy for resectable rectal cancer: a meta-analysis JAMA 284 2000 1008 1015
18. B. Cedermark, H. Johansson, L.E. Rutqvist, N. Wilking Stockholm Colorectal Cancer Study Group The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial Cancer 75 1995 2269 2275
19. Stockholm Colorectal Cancer Study Group Randomized study on preoperative radiotherapy in rectal carcinoma Ann Surg Oncol 3 1996 423 430
20. M. Dahlberg, B. Glimelius, W. Graf, and L. Pahlman Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study Dis Colon Rectum 41 1998 543 549
21. B.D. Minsky Adjuvant therapy of rectal cancer Semin Oncol 26 1999 540 544
22. B. Fisher, N. Wolmark, and H. Rockette Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01 J Natl Cancer Inst 80 1988 21 29
23. M.J. O'Connell, J.A. Martenson, and H.S. Wieand Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 8 1994 502 507
24. Gastrointestinal Tumor Study Group Prolongation of the disease-free interval in surgically treated rectal carcinoma N Engl J Med 312 1985 1465 1472
25. J.E. Krook, C.G. Moertel, and L.L. Gunderson Effective surgical adjuvant therapy for high-risk rectal carcinoma N Engl J Med 324 1991 709 715
26. Gastrointestinal Tumor Study Group Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum J Clin Oncol 10 1992 549 557
27. C. Rodel, G.G. Grabenbauer, C. Shick, T. Papandopulos, W. Hoehnberger, and R. Sauer Preoperative radiation with concurrent 5Fluorouracil for locally-advanced T4 primary rectal cancer Strahlenther Onkol 176 2000 161 167
28. G.M. Videtic, B.J. Fisher, and F.E. Perera Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer Int J Radiat Oncol Biol Phys 42 2 1998 319 324
29. A.K. Chan, A.O. Wong, and J. Langevin Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study Int J Radiat Oncol Biol Phys 48 3 2000 843 856
30. A. Grann, C. Feng, and D. Wong Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma Int J Radiat Oncol Biol Phys 49 2001 987 995
31. V. Valentini, C. Coco, and N. Cellinin Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation in three consecutive studies Int J Radiat Oncol Biol Phys 51 2001 371 383
32. C.G. Moertel, D.S. Childs, and R.J. Reitemeier Combined 5FU and super voltage radiation therapy of locally unresectable gastrointestinal cancer Lancet 2 1969 865 867
33. Cj. Rominger, R.D. Gelber, L.L. Gunderson, N. Conner Radiation Therapy Oncology Group Study Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and recto sigmoid or pelvic recurrence following colorectal surgery Am J Clin Oncol 8 1985 118 127
34. M. Overgaard, K. Bertelsen, and M. Dalmark A randomised feasibility study evaluating the effect of radiotherapy alone or combined with 5FU in the treatment of locally recurrent or inoperable colorectal carcinomas Acta Oncol 32 1993 547 553
35. C.E. Desch, A.B. Benson, and T.J. Smith Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology J Clin Oncol 17 4 1999 1312
36. M. Roh, N. Petrelli, and S. Wieand Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum Proc Am Soc Clin Oncol 20 123a 2001 [abstract 490]
37. R. Sauer, R. Fietkau, and C. Wittekind Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94 Colorectal Dis 5 5 2003 406 415
38. G.J. Frykholm, B. Glimelius, and L. Pahlman Preoperative and postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects Dis Colon Rectum 36 1993 564 572
39. C.F. Kollmorgen, A.P. Meagher, B.G. Wolff, J.H. Pemberton, J.A. Martenson, and D.M. Illstrup The long-term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function Ann Surg 220 1994 676 682
40. P.B. Paty, W.E. Enker, A.M. Cohen, B.D. Minsky, and H. Friedlander-Klar Long-term functional results of coloanal anastomosis for rectal cancer Am J Surg 167 1994 90 95
41. B.D. Minsky, J.A. Conti, Y. Huang, and K. Knopf The relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer J Clin Oncol 13 1995 1409 1416
42. A.K. Chan, A.O. Wong, and J. Langevin Sandwich preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival Int J Radiat Oncol Biol Phys 37 3 1997 629 637
43. T.A. Rich, J.M. Skibber, and J.A. Ajani Preoperative infusional chemoradiation therapy for stage T3 rectal cancer Int J Radiat Oncol Biol Phys 32 4 1995 1025 1029
44. R.D. Marsh, N.M. Chu, and J.N. Vauthey Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5FU infusion and radiation therapy Cancer 78 1996 217 225
45. B.D. Minsky, A.M. Cohen, and N. Kemeny Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach J Clin Oncol 10 1992 1218 1224
46. A. Grann, B.D. Minsky, and A.M. Cohen Preliminary results of preoperative 5FU, low-dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer Dis Colon Rectum 40 1997 515 522
47. R.S. Chari, D.S. Tyler, and M.S. Anscher Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum Ann Surg 221 1995 778 787
48. S.J. Stryker, K.D. Kiel, A. Rademaker, J.M. Shaw, G.T. Ujiki, and S.M. Poticha Preoperative "chemoradiation" for stages II and III rectal carcinoma Arch Surg 131 1996 514 519
49. S. Pucciarelli, M.L. Friso, and P. Toppan Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results Ann Surg Oncol 7 1 2000 38 44
50. W.E. Enker, N. Merchant, and A.M. Cohen Safety and efficacy of low anterior resection for rectal cancer. 681 consecutive cases from a specialty service Ann Surg 230 1999 544 554
51. B.S. Ooi, J.J. Tjandra, and M.D. Green Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer Dis Colon Rectum 42 1999 403 418
52. B.D. Minsky Multidisciplinary management of resectable rectal cancer Oncology 10 1996 1701 1714
53. Y. Francois, C.J. Nemoz, and J. Baulieux Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomised trial J Clin Oncol 17 8 1999 2396 2399
54. J. Garcia-Aguilar, E. Hernandez de Anda, P. Sirivongs, S.H. Lee, R.D. Madoff, and D.A. Rothenberger A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 3 2003 298 304
55. L. Ruo, S. Tickoo, and D.S. Klimstra Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy Ann Surg 236 1 2002 75 81
56. B.D. Minsky, A.M. Cohen, and N. Kemeny The efficacy of preoperative 5fluorouracil, high dose leucovorin, and sequential radiation therapy for unresectable rectal cancer Cancer 71 11 1993 3486 3492
57. J.F. Bosset, J.J. Pavy, H.P. Hamers EORTC Radiotherapy Group Determination of the optimal dose of 5fluorouracil when combined with low dose DL-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies Eur J Cancer 29 10 1993 1406 1410
58. R.D. Marsh, N.M. Chu, and J.N. Vauthey Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5fluorouracil infusion and radiation therapy Cancer 78 2 1996 217 225
59. M. Mohiuddin, Regine Wf, and W.J. John Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response Int Radiat Oncol Biol Phys 46 4 2000 883 888
60. M. Streit, U. Jaehde, and S. Stremetzne Five days continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen Ann Oncol 8 11 1997 163 165
61. J.T. Hartmann, C.H. Kohne, H.J. Schmoll, T. Daikeler, L. Kanz, and C. Bokemeyer Is continuous 24-hour infusion of 5-fluorouracil plus high dose folinic-acid effective in patients with progressive or recurrent colorectal cancer? A phase II study Oncology 55 4 1998 320 325
62. M. Schaffer, M. Thoma, R. Wilkowski, P. Schaffer, and E. Duhmke Radiochemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity Onkologie 25 4 2002 352 356
63. E.T. Chen, M. Mohiuddin, H. Brodovsky, G. Fishbein, and G. Markus Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation Int Radiat Oncol Biol Phys 30 1 1994 169 175
64. N.A. Janjan, V.S. Khoo, and J. Abbruzzese Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson cancer Center experience Int Radiat Oncol Biol Phys 44 5 1999 1027 1038
65. S.Y. Ngan, B.H. Burmeister, and R. Fisher Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a phase II trial for the trans-Tasman Radiation Oncology Group Int Radiat Oncol Biol Phys 50 4 2001 883 887
66. V.K. Mehta, J. Poen, and J. Ford Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer Dis Colon Rectum 45 1 2002 143 144
67. I. Chau, M. Allen, and D. Cunningham Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer Br J Cancer 88 7 2003 1017 1024
68. A.K. Chan, A.O. Wong, J. Langevin, and R. Khoo Preoperative concurrent 5fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma Int J Radiat Oncol Biol Phys 25 5 1993 791 799
69. V. Valentini, C. Coco, and A. Picciocchi Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 3 2002 664 674
70. D. Cunningham, J.R. Zalcberg, U. Rathu Tomudex Colorectal Cancer Study Group Final results of a randomised trial comparing "Tomudex" (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer Cancer Ann Oncol 7 1996 961 965
71. R. Pazdur, and M. Vincent "Raltitrexed" (Tomudex) versus 5-fluorouracil plus leucovorin (5FU + LV) in patients with advanced colorectal cancer (ACC): results of a multicenter randomised North American trial Proc Am Soc Clin Oncol 16 220a 1997 [abstract 801]
72. G. Cocconi, D. Cunningham, E. Van Cutsem Tomudex Colorectal Cancer Study Group Open randomised multicenter trial of raltitrexed versus 5-fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer J Clin Oncol 16 1998 2943 2952
73. T.S. Maughan, R.D. James, and D. Kerr Preliminary results of a multicenter randomised trial comparing 3 chemotherapy regimens (de Gramont Lokich and raltitrexed) in metastatic colorectal cancer Proc Am Soc Clin Oncol 18 262a 1999 [abstract 1007]
74. V. Valentini, G.B. Doglietto, and A.G. Morganti Preoperative chemoradiation with raltitrexed (Tomudex) for T2N+ rectal cancers: a phase I study Eur J Cancer 37 16 2001 2050 2055
75. M.A. Gambacorta, F. Micciche, B. Corvari, G. Mantini, and V. Valentini Biological factors and therapeutic modulation in rectal cancer radiotherapy Rays 27 3 2002 219 222
76. F.A. Calvo, M. Gomez-Espi, and J.A. Diaz-Gozales Pathologic downstaging of T3-4Nx rectal cancer after chemoradiation: 5fluorouracil vs tegafur Int J Radiat Oncol Biol Phys 51 5 2001 1264 1270
77. A. de la Torre, S. Ramos, and E.J. Valcarcel Phase II study of chemoradiotherapy with UFT and low doses oral leucovorin in patients with unresectable rectal cancer Int J Radiat Oncol Biol Phys 45 3 1999 629 634
78. P.M. Hoff, N. Janjan, and E.D. Saad Phase I study of preoperatory oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer Clin Oncol 18 29 2000 3529 3534
79. J. Feliu, J. Calvillo, and A. Escribano Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin bolus radiotherapy Ann Oncol 13 5 2002 730 736
80. A.E. Uzcudun, J.F. Battle, J.C. Valasco, M.E. Sanchez Santos, Jde.C. Carpeno, and A.G. Grande Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study Dis Colon Rectum 45 10 2002 1349 1358
81. J. Dunst, T. Teese, and S. Frings Phase I study of capecitabine combined with simultaneous radiotherapy rectal cancer Proc Am Soc Clin Oncol 20 149a 2001 [abstract 592]
82. W.H. Yoon, J.H. Choi, and T. Kim Enhanced tumour residual effect of preoperative chemoradiation using capecitabine for locally advanced rectal cancer Proc Am Soc Clin Oncol 20 104b 2001 [abstract 2165]
83. S. Ngan, J. Zalcberg, and A. Kell A phase I study of capecitabine combined with radiotherapy for locally advanced potentially operable rectal cancer Proc Am Soc Clin Oncol 20 149a 2001 [abstract 591]
84. J. Dunst, T. Reese, and T. Hoelscher Capecitabine combined with radiotherapy as neoadjuvant treatment of locally advanced rectal cancer Proc Am Soc Clin Oncol 22 277 2003 [abstract 1113]
85. J.S. Kim, J.S. Kim, M.J. Cho, K.S. Song, and W.H. Yoon Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 54 2 2002 403 408
86. J.L. Ku, K.A. Yoon, D.Y. Kim, and J.G. Park Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines Eur J Cancer 35 12 1999 1724 1729
87. T.A. Rich, and J.M. Skivver Ajani Int J Radiat Oncol Biol Phys 32 1995
88. U.N. Vaishampayan, E. Ben-Josef, and P.A. Philip A single institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies Int J Radiat Oncol Biol Phys 53 3 2002 675 679
89. V.K. Mehta, C. Cho, and J.M. Ford Phase II trial of preoperative 3D conformal radiotherapy protracted venous infusion 5-fluorouracil, and weekly CPT11, followed by surgery for ultrasound staged T3 rectal cancer Int J Radiat Oncol Biol Phys 55 1 2003 132 137
90. M. Navarro, E. Dotor, and F. Riviera Phase II trial of irinotecan (CPT11) and 5-fluorouracil (5FU) concomitantly with radiotherapy in patients with locally advanced resectable rectal cancer Proc Am Soc Clin Oncol 22 308 2003 [abstract 1235]
91. G. Freyer, N. Bossard, and P. Roemstaing Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial J Clin Oncol 19 9 2001 2433 2438
92. D. Sebag-Montefiore An update report on the MRC CR07 trial Br J Cancer 85 S1 2001 28
93. S. Carraro, E.L. Roca, and C. Cartelli Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin and 5FU in T3-T4 unresectable rectal cancer: a phase II IATTG1 study Int J Radiat Oncol Biol Phys 54 2 2002 397 402
94. J.P. Gérard, O. Chapet, and C. Nemoz Preoperative concurrent radiochemotherapy in locally advanced rectal cancer with high dose radiation and oxaliplatin containing regimen: the Lyon RO-04 phase II trial J Clin Oncol 21 6 2003 1119 1124
95. D. Sebag-Montefiore, R. Glynne-Jones, S. Falk, T. Maughan, and H. Meadows Preoperative radiation and oxaliplatin in combination with 5-fluorouracil (5-FU) and low-dose leucovorin (LV) in locally advanced rectal cancer Proc Am Soc Clin Oncol 21 146a 2002 [abstract 580]
96. C. Aschele, M.L. Friso, and S. Pucciarelli A phase I study of weekly oxaliplatin + 5-fluorouracil continuous infusion in combination with preoperative radiotherapy in locally advanced rectal cancer Proc Am Soc Clin Oncol 21 132a 2002 [abstract 527]
97. K.P. McMullen, and A.W. Blackstock Chemoradiation with novel agents for rectal cancer Clin Colorectal Cancer 2 1 2002 24 30
98. R. Sauer Adjuvant and neoadjuvant radiotherapy and concurrent radiochemotherapy for rectal cancer Pathol Oncol Res 8 1 2002 7 17
99. J. Tabernero, C.A. Butts, and J. Cassidy Capecitabine and oxaliplatin in combination (XELOX) as first line therapy for patients (pts) with metastatic colorectal cancer (MCRC): results of an international multicenter phase II trial Proc Am Soc Clin Oncol 21 133a 2002 [abstract 531]
100. C. Rodel, G.G. Grabenbauer, T. Papadopoulos, W. Hohenberger, H.J. Schmoll, and R. Sauer Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 15,21 16 2003 3098 3104
101. V. Valentini, A.G. Morganti, and S. Luzi Chemoradiation with raltitrexed ('Tomudex') and oxaliplatin in preoperative treatment of stage I/III resectable rectal cancer: a dose-finding study Proc Am Soc Clin Oncol 20 131a 2001 [abstract 520]
102. H. Bouzourene, F.T. Bosman, W. Seelentag, M. Matter, and P. Coucke Importance of tumour regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy Cancer 94 4 2002 1121 1130
103. C. Rödel, G.G. Grabenbauer, and T. Papadopoulos Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer Int J Radiat Oncol Biol Phys 52 2 2002 294 303